Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)
Tamsulosin Hydrochloride Capsule
Product Images NDC 63187-358
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 63187-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)
Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)
Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)
Figure 3A shows the results of a study, displaying the mean increase in peak urine flow rate measured in L/sec. Three treatment groups were given different doses of medication or a placebo. The study lasted for a variable duration of weeks, with a total of 635, 621, 617, 755, 752, 713, and 694 participants in each respective treatment group.*
Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)
The text describes a figure labeled "Figure 3B" which shows the mean increase in peak urine flow rate measured in mL/Sec for a study labeled "Study 2". The figure includes a graph with the x-axis labeled "Duration of Treatment (weeks)" and the y-axis labeled "Mean Increase in Peak Urine Flow Rate (mL/Sec)". The graph shows a line increasing for 20 weeks of treatment. However, there is some unreadable text in the figure that is not available for evaluation.*
63187-358-30 (Tamsulosin Fig6)
This is a description of Tamsulosin HCI 0.4mg, a medication packaged by Proficient Rx LP in Thousand Oaks, CA. The package contains 30 olive green/orange opaque hard gelatin capsules imprinted with L A0 on the cap, and 53 on the body, each filled with white to off-white beadets. Every capsule contains Tamsulosin Hydrochloride USP 0.4mg, and the product has a lot number of 00000 and an expiration date of 00/00/00. The medication is distributed by Rising Health, LLC, Saddle Brook, NJ, and manufactured in India. It should be stored at 20°-25°C (68°77°F) and kept out of the reach of children.*
Chemical Structure (Tamsulosin Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
